Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone

PHASE2

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped Study was completed as per amended protocol. Protocol was amended to close enrollment earlier than initially planned (study continued as per plan).

Conditions

Breast Neoplasms

Interventions

DRUG: Letrozole
DRUG: Afatinib

Sponsor

Translational Research in Oncology

Collaborators

[object Object]